This cell line is derived from triple negative (negative for human epidermal growth factor receptor 2 [HER2], estrogen receptors [ER] and/or progesterone receptors [PR]) breast invasive ductal carcinoma with metastasis to the lungs (Lacroix and Leclercq, 2004). Here, ERBB2 is linked to invasive ductal breast carcinoma.